Expression of cGMP-dependent protein kinase type I in mature white adipocytes

被引:9
|
作者
Leiss, Veronika [1 ,2 ]
Illison, Julia [3 ]
Domes, Katrin [2 ]
Hofmann, Franz [2 ]
Lukowski, Robert [3 ]
机构
[1] Univ Tubingen Hosp, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Tubingen, Germany
[2] Tech Univ Munich, Inst Pharmacol & Toxicol, FOR 923, D-80290 Munich, Germany
[3] Univ Tubingen, Inst Pharm, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany
关键词
Natriuretic peptides; cGMP; PKG; Browning; Adiponectin; Interleukin-6; INSULIN-RESISTANCE; MITOCHONDRIAL BIOGENESIS; ADIPOSE-TISSUE; BROWN FAT; NATRIURETIC PEPTIDES; SMOOTH-MUSCLE; OBESITY; ADIPONECTIN; MICE; LIPOLYSIS;
D O I
10.1016/j.bbrc.2014.08.071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The presence of cGMP-dependent protein kinase I (cGKI) in murine adipocytes has been questioned, although cGKI was implicated in the thermogenic program of fat cells (FCs) and to exert anti-hypertrophic/inflammatory effects in white adipose tissue. Herein, cGKI was detected in adipocytes from control mice, whereas FCs from global cGKI knockouts (cGKI(-/-)) and cGKI alpha rescue (alpha RM) mice remained cGKI-negative. cGKI mutants exhibit decreased adipocyte size, plasma leptin levels and reduced body-weights as compared to litter-matched controls. Low abundance of adiponectin in WAT and plasma of alpha RM animals together with previously confirmed high IL-6 levels indicate a low-grade inflammation. However, alpha RMs were protected from streptozotocin-induced hyperglycemia. Our results suggest that cGMP/cGKI affects both glucose and FC homeostasis in more complex mode than previously thought. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 50 条
  • [1] Expression of cGMP-dependent protein kinase type I in the murine CNS and eye
    Feil, S
    Zimmermann, P
    Knorn, A
    Brummer, S
    Schlossmann, J
    Hofmann, F
    Feil, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R52 - R52
  • [2] Expression and function of cGMP-dependent protein kinase type I during medaka fish embryogenesis
    Yamamoto, T
    Suzuki, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) : 16979 - 16986
  • [3] cDNA cloning and gene expression of human type I alpha cGMP-dependent protein kinase
    Tamura, N
    Itoh, H
    Ogawa, Y
    Nakagawa, O
    Harada, M
    Chun, TH
    Suga, S
    Yoshimasa, T
    Nakao, K
    HYPERTENSION, 1996, 27 (03) : 552 - 557
  • [4] Expression of cGMP-dependent protein kinase in human atrium
    Mishra, M
    Wagner, MB
    Wang, YG
    Joyner, RW
    Kumar, R
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (08) : 1467 - 1476
  • [5] Activation profile of cGMP-dependent protein kinase Iα
    Sabine Wolter
    Marina Golombek
    Frank Schwede
    Hans-Gottfried Genieser
    Stefan Dove
    Roland Seifert
    BMC Pharmacology and Toxicology, 14 (Suppl 1)
  • [6] Autophosphorylation of cGMP-dependent protein kinase type II
    Vaandrager, AB
    Hogema, BM
    Edixhoven, M
    van den Burg, CMM
    Bot, AGM
    Klatt, P
    Ruth, P
    Hofmann, F
    Van Damme, J
    Vandekerckhove, J
    de Jonge, HR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) : 28651 - 28658
  • [7] Conditional inactivation of the gene encoding cGMP-dependent protein kinase type I
    Wolfsgruber, W
    Kühbandner, S
    Brummer, S
    Feil, R
    Hofmann, F
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R51 - R51
  • [8] Cyclic GMP specifically suppresses Type-Iα cGMP-dependent protein kinase expression by ubiquitination
    Dey, Nupur B.
    Busch, Jennifer L.
    Francis, Sharron H.
    Corbin, Jackie D.
    Lincoln, Thomas M.
    CELLULAR SIGNALLING, 2009, 21 (06) : 859 - 866
  • [9] TRANSIENT EXPRESSION OF TYPE-I-ALPHA AND TYPE-I-BETA ISOFORM OF CGMP-DEPENDENT PROTEIN-KINASE
    RUTH, P
    EGLEME, C
    LANDGRAF, W
    HOFMANN, F
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (09): : 748 - 748
  • [10] Suppression of kidney fibrosis by cGMP-dependent protein kinase I
    Elisabeth Schinner
    Andrea Schramm
    Frieder Kees
    Franz Hofmann
    Jens Schlossmann
    BMC Pharmacology and Toxicology, 14 (Suppl 1)